Intellia Therapeutics NTLA Gain (loss) on disposal of assets
Gain (loss) on disposal of assets at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's gain (loss) on disposal of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's gain (loss) on disposal of assets?
- Intellia Therapeutics (NTLA) reported gain (loss) on disposal of assets of -$904K in Q1 2026.
- How has Intellia Therapeutics's gain (loss) on disposal of assets changed year-over-year?
- Intellia Therapeutics's gain (loss) on disposal of assets increased by 57.5% year-over-year, from -$2.13M to -$904K.
- What does gain (loss) on disposal of assets mean?
- Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.